Holen Sie sich die Stockscreener-App
36.70
2.40%
0.86
Handel nachbörslich:
36.70
Schlusskurs vom Vortag:
$35.84
Offen:
$36.08
24-Stunden-Volumen:
421.79K
Relative Volume:
0.80
Marktkapitalisierung:
$1.82B
Einnahmen:
$447.57M
Nettoeinkommen (Verlust:
$-38.92M
KGV:
-44.22
EPS:
-0.83
Netto-Cashflow:
$-1.15M
1W Leistung:
+0.49%
1M Leistung:
+19.47%
6M Leistung:
-7.30%
1J Leistung:
+63.18%
1-Tages-Spanne:
$35.54
$36.96
1-Wochen-Bereich:
$34.92
$36.98
52-Wochen-Spanne:
$22.36
$43.11
Atricure Inc Stock (ATRC) Company Profile
Firmenname
Atricure Inc
Sektor
Telefon
513-755-4100
Adresse
7555 INNOVATION WAY, MASON, OH
Vergleichen Sie ATRC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATRC
Atricure Inc
|
36.70 | 1.78B | 447.57M | -38.92M | -1.15M | -0.83 |
|
ISRG
Intuitive Surgical Inc
|
482.35 | 171.42B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
195.96 | 55.88B | 21.39B | 1.61B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
86.48 | 42.55B | 9.93B | 1.12B | 1.43B | 2.26 |
|
RMD
Resmed Inc
|
288.28 | 41.48B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
246.22 | 17.25B | 2.90B | 467.20M | 306.90M | 6.37 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-17 | Fortgesetzt | JP Morgan | Overweight |
| 2024-04-23 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2023-10-23 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-09-29 | Eingeleitet | UBS | Buy |
| 2021-08-05 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-12-18 | Bestätigt | Needham | Buy |
| 2020-11-06 | Bestätigt | Needham | Buy |
| 2020-04-07 | Eingeleitet | Oppenheimer | Outperform |
| 2020-02-06 | Eingeleitet | BTIG Research | Buy |
| 2020-01-24 | Bestätigt | Needham | Buy |
| 2019-08-13 | Herabstufung | Northland Capital | Outperform → Market Perform |
| 2019-04-12 | Eingeleitet | JP Morgan | Overweight |
| 2018-10-04 | Bestätigt | Needham | Buy |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-08-02 | Bestätigt | Stifel | Buy |
| 2018-06-18 | Bestätigt | Needham | Buy |
| 2018-04-27 | Bestätigt | Needham | Buy |
| 2018-01-16 | Bestätigt | Needham | Buy |
| 2017-11-02 | Bestätigt | Needham | Buy |
| 2017-07-28 | Bestätigt | Needham | Buy |
| 2017-05-30 | Fortgesetzt | Piper Jaffray | Overweight |
| 2016-06-30 | Fortgesetzt | JMP Securities | Mkt Outperform |
| 2015-10-28 | Bestätigt | Needham | Buy |
| 2015-10-06 | Bestätigt | Canaccord Genuity | Buy |
| 2015-10-06 | Bestätigt | Needham | Buy |
Alle ansehen
Atricure Inc Aktie (ATRC) Neueste Nachrichten
AtriCure at Canaccord Conference: Innovation Fuels Growth By Investing.com - Investing.com Canada
How Investors Are Reacting To AtriCure (ATRC) Raising 2025 Revenue Outlook After Strong Q2 Results - simplywall.st
AtriCure, Inc. : Positioned for Growth in Surgical Afib Solutions - MarketScreener
AtriCure Inc. stock prediction for this weekFree AI Screening for Swing Trade Picks - Newser
Using Bollinger Bands to evaluate AtriCure Inc.Real-Time Entry Signals for Top Stocks - Newser
What makes AtriCure Inc. stock price move sharplySwing Gain Strategy with Entry Forecast - Newser
Visual analytics tools that track AtriCure Inc. performanceEarnings Report Summary with Market Impact - Newser
Atricure Director Makes a Significant Stock Sale! - TipRanks
What technical models suggest about AtriCure Inc.’s comebackOversold Opportunity Scanner with RSI Data - Newser
AtriCure (ATRC) Q2 2025 Earnings Call Transcript - Mitrade
Atricure’s CSO Makes a Strategic Stock Move! - TipRanks
How AtriCure Inc. stock performs during market volatilityPredictive Screener for Daily Trade Watch - Newser
AtriCure CSO Doraiswamy sells $91k in stock By Investing.com - Investing.com Australia
AtriCure CSO Doraiswamy sells $91k in stock - Investing.com
Candlestick signals on AtriCure Inc. stock todayFree Technical Entry Strategy for Beginners - Newser
Momentum Indicator Shows Bearish Divergence in AtriCure Inc.Beginner Friendly Stock Selection Guide Updated - beatles.ru
A Quick Look at Today's Ratings for AtriCure(ATRC.US), With a Forecast Between $42 to $60 - 富途牛牛
Eighteen-Month LeAAPS Trial Enrollment Completed - Medical Product Outsourcing
Building trade automation scripts for AtriCure Inc.Momentum-Based Prediction for Quick Returns - Newser
Wall Street Zen Upgrades AtriCure (NASDAQ:ATRC) to Buy - Defense World
Why AtriCure Inc. stock attracts strong analyst attentionReal Trader Watchlist with Entry Targets - Newser
What drives AtriCure Inc. stock priceMaximize gains with professional stock picks - Jammu Links News
AtriCure Q2 Adjusted Loss Narrows, Revenue Rises - 富途牛牛
When is AtriCure Inc. stock expected to show significant growthAccelerated investment success - Jammu Links News
What catalysts could drive AtriCure Inc. stock higher in 2025Powerful profit generation - Jammu Links News
How many analysts rate AtriCure Inc. as a “Buy”Capitalize on emerging market sectors - Jammu Links News
AtriCure Inc. Stock Analysis and ForecastTriple-digit wealth increases - Jammu Links News
How strong is AtriCure Inc. company’s balance sheetAchieve consistent double-digit growth - Jammu Links News
What are the latest earnings results for AtriCure Inc.Consistent triple returns - Jammu Links News
Is AtriCure Inc. a good long term investmentBuild wealth with proven stock investing tactics - Jammu Links News
What is the dividend policy of AtriCure Inc. stockUnlock powerful trading tools for investors - Jammu Links News
What are AtriCure Inc. company’s key revenue driversCapitalize on emerging market sectors - Jammu Links News
How volatile is AtriCure Inc. stock compared to the marketSuperior return velocity - Jammu Links News
What is the risk reward ratio of investing in AtriCure Inc. stockAchieve rapid portfolio growth with expert help - Jammu Links News
Bollinger Bands Show Potential Breakout in AtriCure Inc.Watchlist for Low Risk High Return Stocks Updated - metal.it
Can AtriCure Inc. Escape Recent Bear ChannelReal Profit Trade Plan Suggestions Shared Widely - metal.it
AtriCure Rings the Opening Bell - Nasdaq
AtriCure, Inc. (NASDAQ:ATRC) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year - simplywall.st
AtriCure Reports Strong Q2 Earnings with Record Growth - The Globe and Mail
Is AtriCure Inc. a growth stock or a value stockChart Pattern Updates With High Returns - Jammu Links News
AtriCure 2025 Q2 Earnings Beats Expectations with 22.7% Net Income Improvement - AInvest
AtriCure, Inc. (NASDAQ:ATRC) Q2 2025 Earnings Call Transcript - Insider Monkey
AtriCure Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Envestnet Asset Management Inc. Boosts Holdings in AtriCure, Inc. (NASDAQ:ATRC) - Defense World
Decoding AtriCure Inc (ATRC): A Strategic SWOT Insight - GuruFocus
AtriCure, Inc. SEC 10-Q Report - TradingView
Numerous AtriCure Insiders Sold Stock: Not A Positive Omen - simplywall.st
Needham raises AtriCure stock price target to $45 on strong Q2 results - Investing.com Canada
Needham raises AtriCure stock price target to $45 on strong Q2 results By Investing.com - Investing.com South Africa
AtriCure stock price target raised to $53 from $51 at Canaccord Genuity - Investing.com Canada
AtriCure (ATRC): Needham Analyst Raises Price Target to $45 | AT - GuruFocus
Finanzdaten der Atricure Inc-Aktie (ATRC)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):